Crimson Publishers Publish With Us Reprints e-Books Video articles


Developments in Anaesthetics & Pain Management

Echinocandin in an Intensive Care Unit: A Pearl’s Peril in Intra Abdominal Post-Operative Carew?

  • Open or Close Alexandra E Lee1 and Vikram Anumakonda2*

    1Senior Honorary Clinical Lecturer, University of Birmingham, UK

    2Consultant Physician, Critical Care Medicine, UK

    *Corresponding author: Vikram Anumakonda, Consultant Physician, Critical Care Medicine, Consultant Physician, Critical Care Medicine, Pensnett Road, Dudley DY1 2HQ

Submission: December 18, 2017; Published: July 19, 2018

Volume1 Issue4
July 2018


Anidulafungin is an echinocandin armamentarium antifungal drug, indicated for use in invasive candidiasis [1]. The mechanism of action is by preventing the synthesis of fungal cell walls [2], However identification and initiation of treatment for invasive candidiasis is difficult and challenging for intensivists in a cohort of critically ill patients during post-operative period. To our knowledge this is the first documented case of such side effects associated with the use of Anidulafungin.

Get access to the full text of this article